Clinical Trials Logo
  1. Home
  2. Coagulopathy
  3. NCT03700723

Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy

Coagulopathy Clinical Trial

Official title:
Multicenter, Single-Blinded, Randomized, Comparator-Controlled Noninferiority Trial to Compare the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy

Clinical Trial Summary

Phase 2a study to assess the safety and efficacy of IV infused spray-dried solvent/detergent -treated plasma (Resusix) when compared with an equal volume of plasma frozen within 24 hours after phlebotomy (FP24) in patients with liver disease who are actively bleeding or who require prophylaxis for surgical bleeding

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03700723
Study type Interventional
Source Entegrion, Inc.
Contact
Status Terminated
Phase Phase 2
Start date December 14, 2018
Completion date April 15, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT01912547 - Thromboelastography During Surgery for Malignant Pleural Mesothelioma Phase 0
Completed NCT03674684 - ROTEM Assessment of Modern Crystalloid, Hydroxyethyl Starch and Gelatin Effect on Coagulation
Recruiting NCT05874843 - Validation of Point-of-care Thromboelastography (TEG 6s) in Pediatric Patients N/A
Withdrawn NCT04705701 - Comparing Post Cardiac Surgery Outcomes in ESRD Patient's With Early Dialysis Versus Standard Care N/A
Not yet recruiting NCT04515420 - The Influence of Noradrenaline on Coagulation and Fibrinolysis in Severe Isolated Brain Injury
Completed NCT01598831 - Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy Phase 3
Completed NCT04580563 - Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study N/A
Withdrawn NCT04274699 - Clinical Evaluation of the Hemosonics Quantra® Coagulation Monitor in Liver and Multivisceral Transplantation
Terminated NCT02540434 - Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions N/A
Completed NCT02203968 - Fibrinogen in the Initial Resuscitation of Severe Trauma (FiiRST) Phase 1/Phase 2
Unknown status NCT01854476 - Safety and Efficacy Study Comparing Pad-gauze With Anti-fibrinolytic Agent Hemostopan™) to a Regular Pad-gauze Phase 2/Phase 3
Completed NCT00816127 - Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction N/A
Active, not recruiting NCT02926274 - Transfusion Using Stored Whole Blood N/A
Completed NCT05295693 - Quantra vs TEG for Congenital Cardiac Surgery - a Pilot Validation Study
Not yet recruiting NCT04582188 - The Early Coagulopathy for the Prognosis in Sepsis
Recruiting NCT04528888 - Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection Phase 3
Recruiting NCT05449834 - Fibrinogen Early In Severe Trauma StudY II Phase 3
Withdrawn NCT04435015 - The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications Phase 1/Phase 2
Not yet recruiting NCT04115722 - Coagulation Parameters in IBD Patients
Completed NCT01228058 - A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients N/A